4.7 Article

Bacteriophage-Antibiotic Combinations for Enterococcus faecium with Varying Bacteriophage and Daptomycin Susceptibilities

Journal

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Volume 64, Issue 9, Pages -

Publisher

AMER SOC MICROBIOLOGY
DOI: 10.1128/AAC.00993-20

Keywords

bacteriophages; bacteriophage-antibiotic combinations; daptomycin; Enterococcus faecium

Funding

  1. NIAID [R01 AI121400, R01 AI141479]
  2. NIH/NIAID [R01 AI134637, R21 AI143229, K24 AI121296]
  3. UTHealth Presidential Award
  4. University of Texas System STARS Award
  5. Ancillia Ltd.
  6. Merck
  7. MemEd Diagnostics
  8. Entasis Therapeutics

Ask authors/readers for more resources

Concerns regarding increased prevalence of daptomycin (DAP)-resistant strains necessitate novel therapies for Enterococcus faecium infections. Obligately lytic bacteriophages are viruses that target, infect, and kill bacterial cells. Limited studies have evaluated phage-antibiotic combinations against E. faecium. After an initial screen of eight E. faecium strains, three strains with varying DAP/phage susceptibilities ere selected for further experiments. Phage-to-strain specificity contributed to synergy with antibiotics by time-kill analyses and was associated with lower development of phage resistance.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available